ADAPTIMMUNE THERAPEUTICS PLC Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value
ADAPTIMMUNE THERAPEUTICS PLC (ADAPY) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of $1.28 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-24.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2025-03-24
- ADAPTIMMUNE THERAPEUTICS PLC share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2024 was $1.28M, a 49.31% decline from fiscal 2023.
- ADAPTIMMUNE THERAPEUTICS PLC share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2023 was $2.53M, a 6.71% increase from fiscal 2022.
- ADAPTIMMUNE THERAPEUTICS PLC share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2022 was $2.37M, a 45.20% decline from fiscal 2021.
- ADAPTIMMUNE THERAPEUTICS PLC share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2021 was $4.32M, a 47.27% decline from fiscal 2020.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month |
|---|---|
| 2024-12-31 | $1.28M 10-K · filed 2025-03-24 |
| 2023-12-31 | $2.53M 10-K · filed 2025-03-24 |
| 2022-12-31 | $2.37M 10-K · filed 2025-03-24 |
| 2021-12-31 | $4.32M 10-K · filed 2024-03-06 |
| 2020-12-31 | $8.20M 10-K · filed 2023-03-06 |
| 2019-12-31 | $1.98M 10-K · filed 2022-03-14 |
| 2018-12-31 | $6.73M 10-K · filed 2021-02-25 |
| 2017-12-31 | $1.52M 10-K · filed 2019-02-27 |
| 2016-12-31 | $40.00K 10-K · filed 2019-02-27 |
| 2014-06-30 | $130.00K 10-K · filed 2017-03-13 |